2-26470685-CCTTCTT-CCTT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_194248.3(OTOF):c.3928_3930delAAG(p.Lys1310del) variant causes a conservative inframe deletion change. The variant allele was found at a frequency of 0.000542 in 1,597,930 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00045 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00055 ( 1 hom. )
Consequence
OTOF
NM_194248.3 conservative_inframe_deletion
NM_194248.3 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.74
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194248.3 | c.3928_3930delAAG | p.Lys1310del | conservative_inframe_deletion | 32/47 | ENST00000272371.7 | NP_919224.1 | |
OTOF | NM_194323.3 | c.1627_1629delAAG | p.Lys543del | conservative_inframe_deletion | 15/29 | ENST00000339598.8 | NP_919304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.3928_3930delAAG | p.Lys1310del | conservative_inframe_deletion | 32/47 | 1 | NM_194248.3 | ENSP00000272371.2 | ||
OTOF | ENST00000339598.8 | c.1627_1629delAAG | p.Lys543del | conservative_inframe_deletion | 15/29 | 1 | NM_194323.3 | ENSP00000344521.3 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 151962Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
68
AN:
151962
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000552 AC: 798AN: 1445854Hom.: 1 AF XY: 0.000513 AC XY: 369AN XY: 719786
GnomAD4 exome
AF:
AC:
798
AN:
1445854
Hom.:
AF XY:
AC XY:
369
AN XY:
719786
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000447 AC: 68AN: 152076Hom.: 0 Cov.: 33 AF XY: 0.000377 AC XY: 28AN XY: 74334
GnomAD4 genome
AF:
AC:
68
AN:
152076
Hom.:
Cov.:
33
AF XY:
AC XY:
28
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The OTOF p.Lys620del variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs759676287) and ClinVar (classified as a VUS by Laboratory for Molecular Medicine). The variant was identified in control databases in 155 of 279488 chromosomes (0 homozygous) at a frequency of 0.0005546 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (Finnish) in 28 of 24002 chromosomes (freq: 0.001167), Other in 7 of 7168 chromosomes (freq: 0.000977), African in 17 of 24838 chromosomes (freq: 0.000684), European (non-Finnish) in 80 of 127520 chromosomes (freq: 0.000627), South Asian in 8 of 30524 chromosomes (freq: 0.000262), Latino in 9 of 35282 chromosomes (freq: 0.000255), East Asian in 4 of 19872 chromosomes (freq: 0.000201), and Ashkenazi Jewish in 2 of 10282 chromosomes (freq: 0.000195). This variant is an in-frame deletion resulting in the removal of a lysine (lys) residue at codon 620; the impact of this alteration on OTOF protein function is not known. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 18, 2024 | In-frame deletion of 1 amino acid in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports a deleterious effect on protein structure/function - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | This variant, c.3928_3930del, results in the deletion of 1 amino acid(s) of the OTOF protein (p.Lys1310del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individual(s) with deafness (Invitae). ClinVar contains an entry for this variant (Variation ID: 229078). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 12, 2015 | The p.Lys1310del variant in OTOF has not been previously reported in individuals with hearing loss, but has been identified in 0.1% (10/10350) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org) . This variant is predicted to lead to a deletion of a lysine residue at positio n 1310 in a poly-lysine tract and not to alter the protein reading-frame. It is unclear whether this deletion will impact the protein. In summary, the clinical significance of the p.Lys1310del variant is uncertain. - |
OTOF-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 22, 2024 | The OTOF c.3928_3930delAAG variant is predicted to result in an in-frame deletion (p.Lys1310del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.12% of alleles in individuals of European (Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Autosomal recessive nonsyndromic hearing loss 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 13, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at